Stories

Alkermes Completes Acquisition to Avadel

Alkermes Completes Acquisition to Avadel

Alkermes plc closed its $2.3 billion acquisition of Avadel Pharmaceuticals, gaining the FDA-approved narcolepsy drug Lumryz and expertise in sleep…